Association between poverty and lack of insurance on mortality rates at 1, 2, and 5 years in patients with breast cancer metastatic to the spine: a propensity score-matched analysis of 854 patients.
Jul 2026· Journal of Neurosurgery : Spine· pp.
1-11
· 0 citations· 53 references
Medicine
TL;DR
This is the first study to demonstrate poverty and insurance status as independent predictors of survival at 1, 2, and 5 years in patients with breast cancer metastatic to the spine.
Abstract
Objective
Metastatic cancer to the spine presents a growing challenge in the US, with surgery often recommended for stability and palliation. Despite advancements, postoperative complication and mortality rates remain high. In this study, the authors aimed to investigate the impact of poverty and social determinants of health on survival rates among patients with metastatic breast cancer to the spine.
Methods
A propensity score-matched retrospective study of patients aged > 18 years receiving a diagnosis of metastatic breast cancer to the spine between 2006 and 2015 was performed using data from the US Surveillance, Epidemiology, and End Results (SEER) sites in the SEER-Medicare database. Poverty census, dual eligibility, race, tumor characteristics (grade, stage, receptor status), community distress score, education level, insurance status at diagnosis, income level, and marital status were evaluated in the model.
Results
Of 854 patients, 651 resided in zip codes in which 0% to < 20% of the population lived below the poverty line and 203 patients resided in zip codes in which 20%-100% lived below the poverty line. After propensity score matching, patients living in areas with 20%-100% of the population below the poverty line had worse survival at 1 year (HR 1.43, p = 0.009), 2 years (HR 1.45, p = 0.008) and 5 years (HR 1.5, p = 0.007) after diagnosis. Patients with insurance, both non-Medicaid and Medicaid, respectively, had higher survival at 1 year (HR 0.389, p = 0.009) and (HR 0.429, p = 0.006), at 2 years (HR 0.359, p = 0.003) and (HR 0.444, p = 0.008), and at 5 years (HR 0.446, p = 0.01) and (HR 0.513, p = 0.037) compared with patients with no insurance.
Conclusions
This is the first study to demonstrate poverty and insurance status as independent predictors of survival at 1, 2, and 5 years in patients with breast cancer metastatic to the spine.
Among US patients with kidney cancer in SEER, SES disadvantage was associated with later diagnosis, lower partial nephrectomy use, and worse survival, and a newly developed composite socioeconomic status (SES) risk score and stratification showed a stepwise gradient.
Shiqiang Zhang, Yiyu Sheng, Yiran Wang et al.· World journal of urology· 0 citations
Abstract Background Numerous studies examine the impact of cancer and disability on health-care use, financial toxicity, and health outcomes but not the relationship between cancer and disability. This study investigates whether and how cancer characteristics are associated with disability status (Social Security Disab...
H. Tak, Ya-Chen Tina Shih, Brandon L. Grimm et al.· JNCI Cancer Spectrum· 0 citations
PIR emerged as a robust predictor of comorbid CVD with strongest protection among younger, racial/ethnic minority, and early-survivorship subgroups, and support extending clinical guidance for CVD prevention beyond the current 5-year threshold and integrating economic screening into survivorship care.
Robina Josiah Willock, D. Parks, Samah Nabi et al.· Journal of cancer survivorsh...· 0 citations
BACKGROUND
Curative-intent resection of colorectal liver metastases (CRLM) offers an opportunity for long-term survival, yet access barriers correlated with area-level socioeconomic status (SES) and rurality may drive disparities in cancer care. Prior work shows lower liver-directed therapy use and survival in socioeco...
Mayte Bryce-Alberti, Victoria Stoffel, Isabella Blanchard et al.· Annals of Surgical Oncology· 0 citations
BackgroundMedicaid expansion under the Affordable Care Act (ACA) was designed to improve access to care for low-income adults, but its impact on cancer survival may vary across diseases depending on differences in screening, stage at diagnosis, and treatment pathways.MethodsWe conducted a retrospective cohort study usi...
Oluwasegun A. Akinyemi, J. Heath, Oladayo A. Oyebanji et al.· The American surgeon· 0 citations
Higher levels of SVI and being insured by Medicare or public insurance are associated with worse survival among adults with breast, prostate, CRC, and lung cancer in Alabama with stronger effects observed among those diagnosed under <65, indicating that age at diagnosis is important in contextualizing and understanding...
Mackenzie E. Fowler, Geetanjali Saini, Elizabeth H. Baker et al.· Journal of Geriatric Oncolog...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.